Alpha-Synuclein Gene Alterations Modulate Tyrosine Hydroxylase in Human iPSC-Derived Neurons in a Parkinson's Disease Animal Model

Luis Daniel Bernal-Conde,Verónica Peña-Martínez,C. Alejandra Morato-Torres,Rodrigo Ramos-Acevedo,Óscar Arias-Carrión,Francisco J. Padilla-Godínez,Alexa Delgado-González,Marcela Palomero-Rivero,Omar Collazo-Navarrete,Luis O. Soto-Rojas,Margarita Gómez-Chavarín,Birgitt Schüle,Magdalena Guerra-Crespo

DOI: https://doi.org/10.3390/life14060728

2024-06-06

Life

Abstract:Parkinson's disease (PD) caused by SNCA gene triplication (3XSNCA) leads to early onset, rapid progression, and often dementia. Understanding the impact of 3XSNCA and its absence is crucial. This study investigates the differentiation of human induced pluripotent stem cell (hiPSC)-derived floor-plate progenitors into dopaminergic neurons. Three different genotypes were evaluated in this study: patient-derived hiPSCs with 3XSNCA, a gene-edited isogenic line with a frame-shift mutation on all SNCA alleles (SNCA 4KO), and a normal wild-type control. Our aim was to assess how the substantia nigra pars compacta (SNpc) microenvironment, damaged by 6-hydroxydopamine (6-OHDA), influences tyrosine hydroxylase-positive (Th+) neuron differentiation in these genetic variations. This study confirms successful in vitro differentiation into neuronal lineage in all cell lines. However, the SNCA 4KO line showed unusual LIM homeobox transcription factor 1 alpha (Lmx1a) extranuclear distribution. Crucially, both 3XSNCA and SNCA 4KO lines had reduced Th+ neuron expression, despite initial successful neuronal differentiation after two months post-transplantation. This indicates that while the SNpc environment supports early neuronal survival, SNCA gene alterations—either amplification or knock-out—negatively impact Th+ dopaminergic neuron maturation. These findings highlight SNCA's critical role in PD and underscore the value of hiPSC models in studying neurodegenerative diseases.

biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: to study how the changes in the α - synuclein (SNCA) gene affect the tyrosine hydroxylase (Th+) expression in human - induced pluripotent stem cell (hiPSC) - derived midbrain dopaminergic neurons in Parkinson's disease (PD) animal models. Specifically, the main research objectives include: 1. **Evaluate the effects of over - expression and deletion of the α - synuclein gene on the differentiation of hiPSCs into Th+ neurons**: - The study used three different hiPSC lines: patient - derived cells carrying the 3X SNCA gene, isogenic cells with SNCA gene knockout (SNCA 4KO), and wild - type cells from unaffected siblings. - The aim was to explore whether these gene changes would affect the ability of hiPSCs to differentiate into dopaminergic neurons and the survival and maturation of these cells after being transplanted into the 6 - OHDA - lesioned substantia nigra pars compacta (SNpc). 2. **Understand the effects of SNCA gene changes on the differentiation of Th+ neurons**: - The researchers focused on the effects of SNCA gene changes (whether triploid or complete knockout) on the differentiation of Th+ neurons, especially in the early stage after transplantation. - By analyzing the performance of different genotypes of hiPSC in vitro and in vivo, the researchers hope to reveal the role of the SNCA gene in the development and maintenance of dopaminergic neurons. 3. **Explore the effects of SNCA gene changes on the distribution of LIM homeobox transcription factor 1α (Lmx1a)**: - Lmx1a is a key transcription factor in the development of midbrain dopaminergic neurons. The study found that SNCA 4KO cells showed abnormal extracellular distribution of Lmx1a, which may affect the normal development of neurons. In summary, this study aims to deeply understand the role of the SNCA gene in the pathological development of Parkinson's disease through the hiPSC model, especially its regulatory mechanism for the differentiation and maturation of dopaminergic neurons. This is of great significance for the development of new treatment strategies based on cell replacement therapy.

Alpha-Synuclein Gene Alterations Modulate Tyrosine Hydroxylase in Human iPSC-Derived Neurons in a Parkinson's Disease Animal Model

Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications

In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition

Dopamine and cortical iPSC-derived neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction: implications for protein deposition versus selective cell loss

Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease

Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson’s Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology

Dopaminergic neuron loss in mice due to increased levels of wild-type human α-Synuclein only takes place under conditions of accelerated aging

Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease

High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification

Templating of Monomeric Alpha-Synuclein Induces Inflammation and SNpc Dopamine Neuron Death in a Genetic Mouse Model of Synucleinopathy.

Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson’s Disease Point Mutation A30P

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson's disease patients

iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates

Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs

Neural stem cells derived from α-synuclein-knockdown iPS cells alleviate Parkinson's disease

Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations

Generation of TWO G51D SNCA missense mutation iPSC lines (CRICKi011-A, CRICKi012-A) from two individuals at risk of Parkinson's disease

Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification

Human tripartite cortical network model for temporal assessment of alpha-synuclein aggregation and propagation in Parkinson's Disease

Single-Cell Transcriptomics and In Vitro Lineage Tracing Reveals Differential Susceptibility of Human iPSC-Derived Midbrain Dopaminergic Neurons in a Cellular Model of Parkinson's Disease

Modeling Parkinson's disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines